Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> New Publication <<
September 20, 2024
Lessons from the Change Healthcare Ransomware Attack. JAMA Health Forum 2024; 5:e242764.
Public Comment
August 13, 2024
Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]
AcademyHealth Annual Research Meeting - Baltimore
June 29-July 2, 2024
CNBC
November 5, 2024
by Annika Kim Constantino
Wired
October 31, 2024
RFK Jr. wants to reshape US health policy. Good luck with that
by Emily Mullin and Matt Reynolds
STAT and The Examination
October 21, 2024
Former FDA lawyers join tobacco industry in ‘epic’ fight against the agency
by Kathryn Kranhold